Control Versus Liberal Cardiac Frequency in Patients in Sepse With Atrial Fibrillation of High Ventricular Response
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 126 participants.
Also called NCT03715556
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 126 participants
- Registry
-
NCT03715556
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Unknown status
Technical summary
Registry record NCT03715556. Randomized; double masking; primary purpose treatment. Start 2018-12-01 (anticipated); primary completion 2020-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Control Versus Liberal Cardiac Frequency in Patients in Sepse With Atrial Fibrillation of High Ventricular Response
- Acronym
- FAARV
- Condition
- Sepsis
- Condition
- Septic Shock
- Condition
- Atrial Fibrillation
- Condition
- Ventricular Fibrillation
- Condition
- Atrial Fibrillation Rapid
- Intervention (Drug)
- Amiodarone
- Intervention (Drug)
- 0.9% physiological solution
- Lead sponsor
- University of Sao Paulo General Hospital
Record details
- Record id
cardio:ct-nct03715556- Content hash
9e7c3f97994dcd80de52bc7027f415c3aa90ed748696d849c5ae1eb04c21ae59